0 XP   0   0   0

Malaysian Genomics Resource
Buy or Sell?

Welcome Invester! I guess you are interested in Malaysian Genomics Resource. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Malaysian Genomics Resource. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Malaysian Genomics Resource even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Malaysian Genomics Resource is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Malaysian Genomics Resource. The closing price on 2022-09-30 was RM0.71 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Malaysian Genomics Resource Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Malaysian Genomics Resource.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Malaysian Genomics Resource earns for each RM1 of revenue.

  • Above 10% is considered healthy but always compare Malaysian Genomics Resource to the Life Sciences Tools & Services industry mean.
  • A Net Profit Margin of -46.6% means that RM-0.47 for each RM1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Malaysian Genomics Resource:

  • The MRQ is 38.6%. The company is making a huge profit. +2
  • The TTM is -46.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ38.6%TTM-46.6%+85.2%
TTM-46.6%YOY-72.6%+26.0%
TTM-46.6%5Y-43.2%-3.3%
5Y-43.2%10Y-43.2%0.0%
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ38.6%4.6%+34.0%
TTM-46.6%0.4%-47.0%
YOY-72.6%20.3%-92.9%
5Y-43.2%-2.0%-41.2%
10Y-43.2%-2.0%-41.2%
1.1.2. Return on Assets

Shows how efficient Malaysian Genomics Resource is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Malaysian Genomics Resource to the Life Sciences Tools & Services industry mean.
  • -2.4% Return on Assets means that Malaysian Genomics Resource generated RM-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Malaysian Genomics Resource:

  • The MRQ is 5.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is -2.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ5.6%TTM-2.4%+8.0%
TTM-2.4%YOY32.6%-35.0%
TTM-2.4%5Y12.5%-14.8%
5Y12.5%10Y12.5%0.0%
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%0.3%+5.3%
TTM-2.4%0.5%-2.9%
YOY32.6%9.2%+23.4%
5Y12.5%3.2%+9.3%
10Y12.5%3.2%+9.3%
1.1.3. Return on Equity

Shows how efficient Malaysian Genomics Resource is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Malaysian Genomics Resource to the Life Sciences Tools & Services industry mean.
  • 5.9% Return on Equity means the company generated RM0.06 for each RM1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Malaysian Genomics Resource:

  • The MRQ is 5.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -3.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ5.9%TTM-3.5%+9.4%
TTM-3.5%YOY34.8%-38.3%
TTM-3.5%5Y12.5%-16.0%
5Y12.5%10Y12.5%0.0%
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%-1.0%+6.9%
TTM-3.5%1.1%-4.6%
YOY34.8%34.4%+0.4%
5Y12.5%8.4%+4.1%
10Y12.5%8.4%+4.1%

1.2. Operating Efficiency of Malaysian Genomics Resource.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Malaysian Genomics Resource is operating .

  • Measures how much profit Malaysian Genomics Resource makes for each RM1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Malaysian Genomics Resource to the Life Sciences Tools & Services industry mean.
  • An Operating Margin of 0.0% means the company generated RM0.00  for each RM1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Malaysian Genomics Resource:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,204.2%+1,204.2%
TTM-5Y-374.1%+374.1%
5Y-374.1%10Y-374.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Malaysian Genomics Resource is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Life Sciences Tools & Services industry mean).
  • An Operation Ratio of 87.9% means that the operating costs are RM0.88for each RM1 in net sales.

Let's take a look of the Operating Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.879. The company is less efficient in keeping operating costs low.
  • The TTM is 1.406. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.879TTM1.406-0.527
TTM1.406YOY7.289-5.883
TTM1.4065Y3.639-2.234
5Y3.63910Y3.6390.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8791.272-0.393
TTM1.4061.341+0.065
YOY7.2891.061+6.228
5Y3.6390.986+2.653
10Y3.6390.986+2.653

1.3. Liquidity of Malaysian Genomics Resource.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Malaysian Genomics Resource is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Life Sciences Tools & Services industry mean).
  • A Current Ratio of 2,902.6% means the company has RM29.03 in assets for each RM1 in short-term debts.

Let's take a look of the Current Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 29.026. The company is very able to pay all its short-term debts. +2
  • The TTM is 17.857. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ29.026TTM17.857+11.169
TTM17.857YOY14.850+3.007
TTM17.8575Y12.177+5.680
5Y12.17710Y12.1770.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ29.0262.077+26.949
TTM17.8571.956+15.901
YOY14.8501.558+13.292
5Y12.1771.332+10.845
10Y12.1771.332+10.845
1.3.2. Quick Ratio

Measures if Malaysian Genomics Resource is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Life Sciences Tools & Services industry mean)
  • A Quick Ratio of 2,863.1% means the company can pay off RM28.63 for each RM1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 28.631. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 17.380. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ28.631TTM17.380+11.250
TTM17.380YOY14.654+2.726
TTM17.3805Y11.887+5.493
5Y11.88710Y11.8870.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ28.6311.751+26.880
TTM17.3801.679+15.701
YOY14.6542.063+12.591
5Y11.8871.283+10.604
10Y11.8871.283+10.604

1.4. Solvency of Malaysian Genomics Resource.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Malaysian Genomics Resource assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Life Sciences Tools & Services industry mean).
  • A Debt to Asset Ratio of 0.06 means that Malaysian Genomics Resource assets are financed with 5.9% credit (debt) and the remaining percentage (100% - 5.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.059. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.124. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.124-0.066
TTM0.124YOY0.099+0.025
TTM0.1245Y0.214-0.090
5Y0.21410Y0.2140.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0590.371-0.312
TTM0.1240.418-0.294
YOY0.0990.437-0.338
5Y0.2140.476-0.262
10Y0.2140.476-0.262
1.4.2. Debt to Equity Ratio

Measures if Malaysian Genomics Resource is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Life Sciences Tools & Services industry mean).
  • A Debt to Equity ratio of 6.2% means that company has RM0.06 debt for each RM1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.062. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.149. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.149-0.086
TTM0.149YOY0.112+0.037
TTM0.1495Y0.397-0.248
5Y0.39710Y0.3970.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.595-0.533
TTM0.1490.741-0.592
YOY0.1120.777-0.665
5Y0.3970.656-0.259
10Y0.3970.656-0.259

2. Market Valuation of Malaysian Genomics Resource

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Malaysian Genomics Resource.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -79.72 means the investor is paying RM-79.72 for every RM1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Malaysian Genomics Resource:

  • The EOD is -68.611. Company is losing money. -2
  • The MRQ is -79.724. Company is losing money. -2
  • The TTM is -50.112. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-68.611MRQ-79.724+11.113
MRQ-79.724TTM-50.112-29.612
TTM-50.112YOY27.814-77.926
TTM-50.1125Y-6.635-43.477
5Y-6.63510Y-6.6350.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
EOD-68.611-17.294-51.317
MRQ-79.724-19.540-60.184
TTM-50.112-20.937-29.175
YOY27.81427.814+0.000
5Y-6.635-0.770-5.865
10Y-6.635-0.770-5.865
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Malaysian Genomics Resource.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Malaysian Genomics Resource:

  • The MRQ is 0.598. Good. +1
  • The TTM is 0.345. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.345+0.253
TTM0.345YOY-0.595+0.940
TTM0.3455Y0.032+0.313
5Y0.03210Y0.0320.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5980.598+0.000
TTM0.3450.345+0.000
YOY-0.595-0.595+0.000
5Y0.0320.0320.000
10Y0.0320.0320.000

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Malaysian Genomics Resource is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Life Sciences Tools & Services industry mean).
  • A PB ratio of 3.10 means the investor is paying RM3.10 for each RM1 in book value.

Let's take a look of the Price to Book Ratio trends of Malaysian Genomics Resource:

  • The EOD is 2.668. Good. +1
  • The MRQ is 3.101. Neutral. Compare to industry.
  • The TTM is 6.729. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD2.668MRQ3.101-0.432
MRQ3.101TTM6.729-3.629
TTM6.729YOY8.910-2.181
TTM6.7295Y5.179+1.550
5Y5.17910Y5.1790.000
Compared to industry (Life Sciences Tools & Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.6683.367-0.699
MRQ3.1014.089-0.988
TTM6.7295.888+0.841
YOY8.9108.910+0.000
5Y5.1795.446-0.267
10Y5.1795.446-0.267

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Malaysian Genomics Resource compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Gains Per Share--0.0160.024-33%0.012+35%0.020-23%0.020-23%
Book Value Per Share--0.2660.227+17%0.092+188%0.171+55%0.171+55%
Current Ratio--29.02617.857+63%14.850+95%12.177+138%12.177+138%
Debt To Asset Ratio--0.0590.124-53%0.099-41%0.214-73%0.214-73%
Debt To Equity Ratio--0.0620.149-58%0.112-44%0.397-84%0.397-84%
Dividend Per Share----0%0.017-100%0.022-100%0.022-100%
Eps--0.016-0.003+116%0.008+103%0.017-5%0.017-5%
Gains Per Share--0.0160.024-33%0.029-46%0.043-63%0.043-63%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.386-0.466+221%-0.726+288%-0.432+212%-0.432+212%
Operating Margin----0%-12.0420%-3.7410%-3.7410%
Operating Ratio--0.8791.406-37%7.289-88%3.639-76%3.639-76%
Pb Ratio2.668-16%3.1016.729-54%8.910-65%5.179-40%5.179-40%
Pe Ratio-68.611+14%-79.724-50.112-37%27.814-387%-6.635-92%-6.635-92%
Peg Ratio--0.5980.345+73%-0.595+199%0.032+1775%0.032+1775%
Price Per Share0.710-16%0.8251.434-42%0.714+16%0.730+13%0.730+13%
Quick Ratio--28.63117.380+65%14.654+95%11.887+141%11.887+141%
Return On Assets--0.056-0.024+143%0.326-83%0.125-55%0.125-55%
Return On Equity--0.059-0.035+159%0.348-83%0.125-53%0.125-53%
 EOD+2 -1MRQTTM+13 -3YOY+11 -65Y+9 -810Y+9 -8

3.2. Fundamental Score

Let's check the fundamental score of Malaysian Genomics Resource based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-68.611
Price to Book Ratio (EOD)Between0-12.668
Net Profit Margin (MRQ)Greater than00.386
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than128.631
Current Ratio (MRQ)Greater than129.026
Debt to Asset Ratio (MRQ)Less than10.059
Debt to Equity Ratio (MRQ)Less than10.062
Return on Equity (MRQ)Greater than0.150.059
Return on Assets (MRQ)Greater than0.050.056
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Malaysian Genomics Resource based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.575
Ma 20Greater thanMa 500.698
Ma 50Greater thanMa 1000.759
Ma 100Greater thanMa 2000.771
OpenGreater thanClose0.710
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in MYR. All numbers in thousands.

Summary
Total Assets35,105
Total Liabilities2,055
Total Stockholder Equity33,050
 As reported
Total Liabilities 2,055
Total Stockholder Equity+ 33,050
Total Assets = 35,105

Assets

Total Assets35,105
Total Current Assets27,894
Long-term Assets27,894
Total Current Assets
Cash And Cash Equivalents 22,385
Net Receivables 5,129
Inventory 277
Other Current Assets 58
Total Current Assets  (as reported)27,894
Total Current Assets  (calculated)27,849
+/- 45
Long-term Assets
Property Plant Equipment 5,528
Intangible Assets 1,683
Long-term Assets  (as reported)7,211
Long-term Assets  (calculated)7,211
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities961
Long-term Liabilities1,094
Total Stockholder Equity33,050
Total Current Liabilities
Accounts payable 686
Total Current Liabilities  (as reported)961
Total Current Liabilities  (calculated)686
+/- 275
Long-term Liabilities
Long term Debt Total 1,094
Long-term Liabilities  (as reported)1,094
Long-term Liabilities  (calculated)1,094
+/-0
Total Stockholder Equity
Common Stock52,684
Retained Earnings -19,634
Total Stockholder Equity (as reported)33,050
Total Stockholder Equity (calculated)33,050
+/-0
Other
Capital Stock52,684
Cash and Short Term Investments 22,385
Common Stock Shares Outstanding 124,210
Liabilities and Stockholders Equity 35,105
Net Invested Capital 33,050
Net Working Capital 26,933



Balance Sheet

Currency in MYR. All numbers in thousands.

 Trend2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
38,530
37,003
37,068
41,132
14,217
11,086
10,878
9,132
21,348
22,783
36,028
33,068
35,105
35,10533,06836,02822,78321,3489,13210,87811,08614,21741,13237,06837,00338,530
   > Total Current Assets 
15,018
13,663
13,642
41,078
14,174
9,206
7,963
6,092
18,420
15,663
28,982
26,054
27,894
27,89426,05428,98215,66318,4206,0927,9639,20614,17441,07813,64213,66315,018
       Cash And Cash Equivalents 
5,361
4,210
3,817
36,258
9,508
0
6,811
4,122
13,544
11,309
21,477
22,184
22,385
22,38522,18421,47711,30913,5444,1226,81109,50836,2583,8174,2105,361
       Net Receivables 
7,444
6,889
8,151
4,708
4,514
2,953
959
1,828
4,787
3,953
6,775
2,853
5,129
5,1292,8536,7753,9534,7871,8289592,9534,5144,7088,1516,8897,444
       Inventory 
1,988
1,585
1,508
65
90
84
68
56
37
307
639
939
277
2779396393073756688490651,5081,5851,988
       Other Current Assets 
63
10
7
4
12
55
87
42
3
40
31
13
58
58133140342875512471063
   > Long-term Assets 
23,512
23,340
23,426
54
43
0
2,915
3,040
2,928
7,120
7,046
7,014
7,211
7,2117,0147,0467,1202,9283,0402,9150435423,42623,34023,512
       Property Plant Equipment 
14,479
14,314
14,408
54
43
36
1,094
1,242
1,153
5,368
5,317
5,308
5,528
5,5285,3085,3175,3681,1531,2421,09436435414,40814,31414,479
       Goodwill 
0
8,828
0
0
0
0
0
0
0
0
0
0
0
000000000008,8280
       Intangible Assets 
9,033
197
9,018
0
0
1,844
1,821
1,798
1,775
1,752
1,729
1,706
1,683
1,6831,7061,7291,7521,7751,7981,8211,844009,0181979,033
> Total Liabilities 
21,255
21,073
21,353
3,836
1,356
828
1,453
1,261
1,052
4,853
5,953
1,982
2,055
2,0551,9825,9534,8531,0521,2611,4538281,3563,83621,35321,07321,255
   > Total Current Liabilities 
6,458
7,068
6,637
3,836
1,356
828
816
723
612
3,551
4,720
818
961
9618184,7203,5516127238168281,3563,8366,6377,0686,458
       Short-term Debt 
3,918
4,002
2,960
2,602
0
0
0
0
0
0
0
0
0
0000000002,6022,9604,0023,918
       Short Long Term Debt 
3,918
4,002
2,960
2,602
0
0
0
0
0
0
0
0
0
0000000002,6022,9604,0023,918
       Accounts payable 
2,490
1,748
3,279
1,234
1,356
0
444
316
211
7
4,387
502
686
6865024,387721131644401,3561,2343,2791,7482,490
       Other Current Liabilities 
50
0
0
0
0
0
0
0
0
0
0
0
0
00000000000050
   > Long-term Liabilities 
14,797
14,005
14,716
0
0
0
637
538
440
1,302
1,233
1,164
1,094
1,0941,1641,2331,30244053863700014,71614,00514,797
       Long term Debt Total 
14,121
13,268
13,982
0
0
0
637
538
440
1,302
1,233
1,164
1,094
1,0941,1641,2331,30244053863700013,98213,26814,121
> Total Stockholder Equity
17,275
15,930
15,715
37,296
12,861
10,258
9,425
7,871
20,296
17,930
30,075
31,086
33,050
33,05031,08630,07517,93020,2967,8719,42510,25812,86137,29615,71515,93017,275
   Common Stock
28,489
28,489
28,489
28,489
28,489
28,489
28,489
28,489
40,714
40,714
52,684
52,684
52,684
52,68452,68452,68440,71440,71428,48928,48928,48928,48928,48928,48928,48928,489
   Retained Earnings 
-11,214
-12,559
-12,774
8,807
-15,628
-18,231
-19,064
-20,618
-20,418
-22,784
-22,609
-21,598
-19,634
-19,634-21,598-22,609-22,784-20,418-20,618-19,064-18,231-15,6288,807-12,774-12,559-11,214
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 0000000000000



Balance Sheet

Currency in MYR. All numbers in thousands.




Cash Flow

Currency in MYR. All numbers in thousands.




Income Statement

Currency in MYR. All numbers in thousands.


Latest Income Statement (annual, 2021-06-30)

Gross Profit (+$)
totalRevenue1,784
Cost of Revenue-571
Gross Profit1,2131,213
 
Operating Income (+$)
Gross Profit1,213
Operating Expense-6,119
Operating Income-4,200-4,906
 
Operating Expense (+$)
Research Development-
Selling General Administrative5,548
Selling And Marketing Expenses-
Operating Expense6,1195,548
 
Net Interest Income (+$)
Interest Income-93
Interest Expense-93
Net Interest Income-93-187
 
Pretax Income (+$)
Operating Income-4,200
Net Interest Income-93
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-4,293-4,200
EBIT - interestExpense = -93
-4,293
-4,200
Interest Expense93
Earnings Before Interest and Taxes (ebit)--4,200
Earnings Before Interest and Taxes (ebitda)-3,616
 
After tax Income (+$)
Income Before Tax-4,293
Tax Provision-0
Net Income From Continuing Ops-4,293-4,293
Net Income-4,293
Net Income Applicable To Common Shares-4,293
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items0
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-93
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
IUSQ.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IUSQ.XETRA.

IUSQ.XETRA Daily Candlestick Chart
IS3G.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS3G.XETRA.

IS3G.XETRA Daily Candlestick Chart
IS0M.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS0M.XETRA.

IS0M.XETRA Daily Candlestick Chart
IQQU.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IQQU.XETRA.

IQQU.XETRA Daily Candlestick Chart
EXX5.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EXX5.XETRA.

EXX5.XETRA Daily Candlestick Chart
EMEC.XETRA
now

I found you a Death Cross on the daily chart of EMEC.XETRA.

EMEC.XETRA Daily Candlestick Chart
KPN.F
now

I found you a Death Cross on the daily chart of KPN.F.

KPN.F Daily Candlestick Chart
DBX9.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DBX9.XETRA.

DBX9.XETRA Daily Candlestick Chart
XCS6.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XCS6.XETRA.

XCS6.XETRA Daily Candlestick Chart
FRA.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FRA.XETRA.

FRA.XETRA Daily Candlestick Chart
IQQW.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IQQW.XETRA.

IQQW.XETRA Daily Candlestick Chart
C004.XETRA
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of C004.XETRA.

C004.XETRA Daily Candlestick Chart
IEVD.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IEVD.XETRA.

IEVD.XETRA Daily Candlestick Chart
IBCJ.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IBCJ.XETRA.

IBCJ.XETRA Daily Candlestick Chart
HNDX.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HNDX.XETRA.

HNDX.XETRA Daily Candlestick Chart
F701.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of F701.XETRA.

F701.XETRA Daily Candlestick Chart
EXV1.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EXV1.XETRA.

EXV1.XETRA Daily Candlestick Chart
EXH8.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EXH8.XETRA.

EXH8.XETRA Daily Candlestick Chart
EUNJ.XETRA
3 minutes ago

I found you a Death Cross on the daily chart of EUNJ.XETRA.

EUNJ.XETRA Daily Candlestick Chart
ETLQ.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ETLQ.XETRA.

ETLQ.XETRA Daily Candlestick Chart
ETLK.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ETLK.XETRA.

ETLK.XETRA Daily Candlestick Chart
EMND.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EMND.XETRA.

EMND.XETRA Daily Candlestick Chart
E909.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of E909.XETRA.

E909.XETRA Daily Candlestick Chart